Substance P acting via the neurokinin-1 receptor regulates adverse myocardial remodeling in a rat model of hypertension
HM Dehlin, EJ Manteufel, AL Monroe… - International journal of …, 2013 - Elsevier
Background Substance P is a sensory nerve neuropeptide located near coronary vessels in
the heart. Therefore, substance P may be one of the first mediators released in the heart in …
the heart. Therefore, substance P may be one of the first mediators released in the heart in …
Substance P in heart failure: the good and the bad
HM Dehlin, SP Levick - International journal of cardiology, 2014 - Elsevier
The tachykinin, substance P, is found primarily in sensory nerves. In the heart, substance P-
containing nerve fibers are often found surrounding coronary vessels, making them ideally …
containing nerve fibers are often found surrounding coronary vessels, making them ideally …
Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells
GC Melendez, J Li, BA Law, JS Janicki… - Cardiovascular …, 2011 - academic.oup.com
Aims Substance P and neurokinin A (NKA) are sensory nerve neuropeptides encoded by
the TAC1 gene. Substance P is a mast cell secretagogue and mast cells are known to play a …
the TAC1 gene. Substance P is a mast cell secretagogue and mast cells are known to play a …
[HTML][HTML] Regulation of cardiac mast cell maturation and function by the neurokinin-1 receptor in the fibrotic heart
A Widiapradja, EJ Manteufel, HM Dehlin, J Pena… - Scientific Reports, 2019 - nature.com
Cardiac fibrosis is an underlying cause of diastolic dysfunction, contributing to heart failure.
Substance P (SP) activation of the neurokinin-1 receptor (NK-1R) contributes to cardiac …
Substance P (SP) activation of the neurokinin-1 receptor (NK-1R) contributes to cardiac …
Implication of Substance P in myocardial contractile function during ischemia in rats
LL Wang, Z Guo, Y Han, PF Wang, RL Zhang… - Regulatory peptides, 2011 - Elsevier
Evidence suggests that substance P (SP) participates in the pathology of acute myocardial
ischemia and infarction but the profiles of the peptide in regulation of cardiac functions are …
ischemia and infarction but the profiles of the peptide in regulation of cardiac functions are …
Non-human primate and rat cardiac fibroblasts show similar extracellular matrix-related and cellular adhesion gene responses to substance P
GC Meléndez, EJ Manteufel, HM Dehlin… - Heart, Lung and …, 2015 - Elsevier
Background The sensory nerve neuropeptide substance P (SP) regulates cardiac fibrosis in
rodents under pressure overload conditions. Interestingly, SP induces transient increased …
rodents under pressure overload conditions. Interestingly, SP induces transient increased …
[HTML][HTML] Replacement of lost substance P reduces fibrosis in the diabetic heart by preventing adverse fibroblast and macrophage phenotype changes
A Widiapradja, AO Kasparian, SL McCaffrey, LL Kolb… - Cells, 2021 - mdpi.com
Reduced levels of the sensory nerve neuropeptide substance P (SP) have been reported in
the diabetic rat heart, the consequence being a loss of cardioprotection in response to …
the diabetic rat heart, the consequence being a loss of cardioprotection in response to …
NPY1–36 and PYY1–36 activate cardiac fibroblasts: an effect enhanced by genetic hypertension and inhibition of dipeptidyl peptidase 4
X Zhu, DG Gillespie… - American Journal of …, 2015 - journals.physiology.org
Cardiac sympathetic nerves release neuropeptide Y (NPY) 1–36, and peptide YY (PYY) 1–
36 is a circulating peptide; therefore, these PP-fold peptides could affect cardiac fibroblasts …
36 is a circulating peptide; therefore, these PP-fold peptides could affect cardiac fibroblasts …
Angiotensin-(1–7) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1
LTT McCollum, PE Gallagher… - American Journal of …, 2012 - journals.physiology.org
Chronic hypertension induces cardiac remodeling, including left ventricular hypertrophy and
fibrosis, through a combination of both hemodynamic and humoral factors. In previous …
fibrosis, through a combination of both hemodynamic and humoral factors. In previous …
[HTML][HTML] Replacement substance P reduces cardiac fibrosis in monkeys with type 2 diabetes
GC Meléndez, K Kavanagh, N Gharraee… - Biomedicine & …, 2023 - Elsevier
Background Type 2 diabetes mellitus (T2DM)-associated cardiac fibrosis contributes to heart
failure. We previously showed that diabetic mice with cardiomyopathy, including cardiac …
failure. We previously showed that diabetic mice with cardiomyopathy, including cardiac …